Page 1 | Search Results | Blood | American Society of Hematology

1-14 of 14

Sort by

Sort Order Select

Journal Articles

Durable Remission of Refractory and Advanced Stage Mycosis Fungoides/Sezary Syndrome (MF/SS) Utilizing an "Outpatient" Alemtuzumab and Fludarabine-Based Reduced Intensity Allogeneic Peripheral Blood Stem Cell Transplantation (PBSCT)

Phuong Vo, Ramaprasad Srinivasan, Enkhtsetseg Purev, MD PhD, Emily McDuffee, Lisa Cook, Tatyana Worthy, Geri Hawks, Prince Patricia, Reem Shalabi, Brian Wells, Robert Reger, MS, Hanh Khuu, David Stroncek, Xin Tian, PhD, Nancy Geller, Georg Aue, Richard Childs, MD

Blood (2017) 130 (Supplement 1): 1962.

https://doi.org/10.1182/blood.V130.Suppl_1.1962.1962

Published: 2017

Journal Articles

Early Adoptive Transfer of Ex Vivo Generated Multi-Virus Specific T Cells Is a Safe Strategy to Prevent Viral Reactivation in Recipients of Allogeneic T Cell Depleted Stem Cell Transplant

Pawel Muranski, MD, Greg Whitehill, BS, Debbie Draper, RN, Eleftheria Koklanaris, RN, Jeanine Superata, RN, Quan Yu, MS, Marianna Sabatino, MD, Steven L. Highfill, PhD, Hanh Khuu, MD, Sarah I Davies, Mark Chang, Upneet Chawla, BS, MD, Alexandros Spyridonidis, MD PhD, Gary Fahle, MT,SM, Sawa Ito, MD PhD, David Stroncek, MD, Minoo Battiwalla, MDMS, John Barrett, MD

Blood (2016) 128 (22): 979.

https://doi.org/10.1182/blood.V128.22.979.979

Published: 2016

Journal Articles

Myeloid Cells in Peripheral Blood Mononuclear Cell (PMBC) Concentrates Inhibit the Expansion of Chimeric Antigen Receptor (CAR) T Cells

David F. Stroncek, MD, Daniel W. Lee, III, MD, Jiaqiang Ren, MD PhD, Marianna Sabatino, MD, Hanh Khuu, MD, Melinda S. Merchant, MD, Crystal L. Mackall, MD

Blood (2015) 126 (23): 383.

https://doi.org/10.1182/blood.V126.23.383.383

Published: 2015

Journal Articles

FLT Imaging Reveals Kinetics and Biology of Engraftment after Myeloablative HSCT

Blood (2014) 124 (21): 1147.

https://doi.org/10.1182/blood.V124.21.1147.1147

Published: 2014

Journal Articles

High Incidence of Late, Sustained and Clinically Inconsequential Epstein Barr Virus (EBV) Reactivation Following Combined Unrelated Cord Blood and Haploidentical CD34+ Cell Transplantation

Sneha Purvey, Enkhtsetseg Purev, Xin Tian, Jennifer Wilder, Lisa Cook, Catalina Ramos, Elena Cho, Patricia Prince, Susan F. Leitman, Hanh Khuu, David Stroncek, Robert N Reger, Georg Aue, Richard W. Childs, MD

Blood (2014) 124 (21): 1180.

https://doi.org/10.1182/blood.V124.21.1180.1180

Published: 2014

Journal Articles

Carfilzomib and Bortezomib Containing Regimens Yield High Rates Of MRD Negative Autologous Hematopoietic Progenitor Cell (HPC) Grafts In Multiple Myeloma (MM) and High Risk Smoldering Myeloma (SMM)

Nishant Tageja, MD, Neha Korde, MD, Constance Yuan, MD, PhD, Kristen Cole, RN, Jennifer Hsu, RN, Sheila Phang, RN, Daniele N. Avila, CRNP, Tiffany Taylor, Marcia Mulquin, RN, Diamond Zuchlinski, RN, Hanh Khuu, MD, Maryalice Stetler-Stevenson, MD, PhD, Susan F. Leitman, MD, Ola Landgren, MD, PhD, Claude Sportes, MD

Blood (2013) 122 (21): 2030.

https://doi.org/10.1182/blood.V122.21.2030.2030

Published: 2013

Journal Articles

Utility Of An Algorithm For Use Of Plerixafor In Filgrastim-based Hematopoietic Progenitor Cell Mobilization In Patients With Plasma Cell Myeloma Treated With Carfilzomib-Lenalidomide-Dexamethasone.

Susan F. Leitman, MD, Nishant Tageja, MD, Neha Korde, MD, Yu Ying Yau, RN, Sheila Phang, RN, Jennifer Hsu, RN, Kristin Cole, RN, Hanh Khuu, MD, Ola Landgren, MD, PhD, Claude Sportes, MD

Blood (2013) 122 (21): 906.

https://doi.org/10.1182/blood.V122.21.906.906

Published: 2013

Journal Articles

Pre-Emptive T-Rapa Cell DLI for Therapy of High-Risk Lymphoma After Low-Intensity Allogeneic HCT

Blood (2012) 120 (21): 471.

https://doi.org/10.1182/blood.V120.21.471.471

Published: 2012

Journal Articles

High Dose Plerixafor Is Safe and Mobilizes Higher Numbers of CD34+ Cells Compared with Standard Dose Plerixafor

Jeremy M Pantin, MB.BS., Xin Tian, Ph.D., Matthew M. Hsieh, MD, Lisa Cook, RN, BSN, Theresa Donohue, MHS, PA-C, Elena Cho, RN MSN, Aleah Smith, Robert Reger, Thomas Trischman, PhD, Hanh Khuu, MD, Richard Childs, MD

Blood (2012) 120 (21): 585.

https://doi.org/10.1182/blood.V120.21.585.585

Published: 2012

Journal Articles

4-Log Ex-Vivo T-Lymphocyte Depleted Myeloablative HLA-Matched Sibling Transplants; a Platform for Adoptive Immunotherapy

Minoo Battiwalla, MD, MS, Zachariah A. McIver, DO, Janice Haggerty, Eleftheria K. Koklanaris, BS, Kamna Chawla, MD, MS, Jeanine Superata, Richard Childs, MD, Roger Kurlander, MD, David Stroncek, MD, Hanh Khuu, Deborah Citrin, Marianna Sabatino, MD, Susan Leitman, MD, A. John Barrett, MD

Blood (2010) 116 (21): 2091.

https://doi.org/10.1182/blood.V116.21.2091.2091

Published: 2010

Journal Articles

T-Rapa Cell Clinical Products Contain a Balance of Minimally Differentiated Th2/Th1 Effector Cells Depleted of Treg Cells

Miriam E. Mossoba, PhD, Jacopo Mariotti, MD, Xiao-Yi Yan, Anu Gangopadhyay, Mathew Winterton, Marianna Sabatino, MD, Hanh Khuu, MD, Vicki Fellowes, Frances T. Hakim, PhD, David Stroncek, MD, Susan Leitman, MD, Bruce L Levine, PhD, Carl H. June, MD, Daniel H Fowler, MD

Blood (2010) 116 (21): 352.

https://doi.org/10.1182/blood.V116.21.352.352

Published: 2010

Journal Articles

Adoptive Transfer of Treg-Depleted Donor Th1 and Th2 Cells Safely Accelerates Alloengraftment After Low-Intensity Chemotherapy

Blood (2010) 116 (21): 521.

https://doi.org/10.1182/blood.V116.21.521.521

Published: 2010

Journal Articles

Allografts Selectively Photodepleted of GvHD Causing T Cells and Followed by Low-Level Immunosuppression: A Novel Method to Improve Disease Control After HLA-Matched Sibling Transplantations.

Stephan Mielke, MD, Aarthi Shenoy, MD, Katayoun Rezvani, MD, PhD, Agnes S. M. Yong, MD, PhD, Zachariah A. McIver, DO, Vicki S. Fellowes, Bipin N. Savani, MD, Roger Kurlander, MD, Hanh Khuu, MD, Carol Boss, A.John Barrett, MD, FRCP

Blood (2009) 114 (22): 515.

https://doi.org/10.1182/blood.V114.22.515.515

Published: 2009

Journal Articles

Selective Allodepletion by TH9402-Mediated Photosensitization Results in Early Full Donor T Cell Reconstitution in the Absence of High-Grade, Acute GvHD and Is Associated with Favorable Outcome after HLA Matched Sibling SCT for Hematologic Malignancies

Stephan Mielke, MD, Aarthi Shenoy, MD, Vicki S. Fellowes, Katayoun Rezvani, MD, PhD, Bipin N. Savani, MD, Laura Musse, Laura Wisch, Roger Kurlander, MD, Hanh Khuu, MD, Carol Boss, A. John Barrett, MD, FRCP

Blood (2008) 112 (11): 1168.

https://doi.org/10.1182/blood.V112.11.1168.1168

Published: 2008

NARROW

Durable Remission of Refractory and Advanced Stage Mycosis Fungoides/Sezary Syndrome (MF/SS) Utilizing an "Outpatient" Alemtuzumab and Fludarabine-Based Reduced Intensity Allogeneic Peripheral Blood Stem Cell Transplantation (PBSCT)

Early Adoptive Transfer of Ex Vivo Generated Multi-Virus Specific T Cells Is a Safe Strategy to Prevent Viral Reactivation in Recipients of Allogeneic T Cell Depleted Stem Cell Transplant

Myeloid Cells in Peripheral Blood Mononuclear Cell (PMBC) Concentrates Inhibit the Expansion of Chimeric Antigen Receptor (CAR) T Cells

FLT Imaging Reveals Kinetics and Biology of Engraftment after Myeloablative HSCT

High Incidence of Late, Sustained and Clinically Inconsequential Epstein Barr Virus (EBV) Reactivation Following Combined Unrelated Cord Blood and Haploidentical CD34+ Cell Transplantation

Carfilzomib and Bortezomib Containing Regimens Yield High Rates Of MRD Negative Autologous Hematopoietic Progenitor Cell (HPC) Grafts In Multiple Myeloma (MM) and High Risk Smoldering Myeloma (SMM)

Utility Of An Algorithm For Use Of Plerixafor In Filgrastim-based Hematopoietic Progenitor Cell Mobilization In Patients With Plasma Cell Myeloma Treated With Carfilzomib-Lenalidomide-Dexamethasone.

Pre-Emptive T-Rapa Cell DLI for Therapy of High-Risk Lymphoma After Low-Intensity Allogeneic HCT

High Dose Plerixafor Is Safe and Mobilizes Higher Numbers of CD34+ Cells Compared with Standard Dose Plerixafor

4-Log Ex-Vivo T-Lymphocyte Depleted Myeloablative HLA-Matched Sibling Transplants; a Platform for Adoptive Immunotherapy

T-Rapa Cell Clinical Products Contain a Balance of Minimally Differentiated Th2/Th1 Effector Cells Depleted of Treg Cells

Adoptive Transfer of Treg-Depleted Donor Th1 and Th2 Cells Safely Accelerates Alloengraftment After Low-Intensity Chemotherapy

Allografts Selectively Photodepleted of GvHD Causing T Cells and Followed by Low-Level Immunosuppression: A Novel Method to Improve Disease Control After HLA-Matched Sibling Transplantations.

Selective Allodepletion by TH9402-Mediated Photosensitization Results in Early Full Donor T Cell Reconstitution in the Absence of High-Grade, Acute GvHD and Is Associated with Favorable Outcome after HLA Matched Sibling SCT for Hematologic Malignancies

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only